BioLineRx (BLRX) Short Interest Ratio & Short Volume $3.63 -0.01 (-0.27%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$3.53 -0.10 (-2.75%) As of 05/21/2025 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioLineRx Short Interest DataBioLineRx (BLRX) has a short interest of 198,800 shares, representing 5.37% of the float (the number of shares available for trading by the public). This marks a -8.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.1, indicating that it would take 5.1 days of the average trading volume of 67,386 shares to cover all short positions.Current Short Interest198,800 sharesPrevious Short Interest217,200 sharesChange Vs. Previous Month-8.47%Dollar Volume Sold Short$689,836.00Short Interest Ratio5.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares3,329,000 sharesFloat Size3,700,000 sharesShort Percent of Float5.37%Today's Trading Volume29,067 sharesAverage Trading Volume67,386 sharesToday's Volume Vs. Average43% Short Selling BioLineRx? Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLRX Short Interest Over TimeBLRX Days to Cover Over TimeBLRX Percentage of Float Shorted Over Time BioLineRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025198,800 shares $689,836.00 -8.5%5.4%5.1 $3.47 4/15/2025217,200 shares $612,504.00 -1.3%5.9%3.1 $2.82 3/31/2025220,000 shares $651,200.00 +6.0%6.0%1.3 $2.96 3/15/2025207,500 shares $655,700.00 -9.5%5.6%1 $3.16 2/28/2025229,200 shares $767,820.00 +5.9%6.2%1.1 $3.35 2/15/2025216,400 shares $802,844.00 +76.1%5.9%1 $3.71 1/31/2025122,900 shares $437,524.00 -90.3%3.3%0.6 $3.56 1/15/20251,260,000 shares $5.27 million +53.3%N/A0.2 $4.18 12/31/2024822,200 shares $175,950.80 -0.7%N/A0.2 $0.21 12/15/2024827,800 shares $186,172.22 -10.2%N/A0.8 $0.22 Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024921,900 shares $276,570.00 -16.2%N/A1.1 $0.30 11/15/20241,100,000 shares $523,160.00 +3.8%N/A1.6 $0.48 10/31/20241,060,000 shares $434,600.00 +70.6%N/A3.5 $0.41 10/15/2024621,400 shares $271,924.64 +351.3%N/A2.2 $0.44 9/30/2024137,700 shares $73,820.97 -23.2%N/A0.5 $0.54 9/15/2024179,200 shares $111,301.12 +28.7%N/A0.7 $0.62 8/31/2024139,200 shares $90,048.48 -47.9%N/A0.5 $0.65 8/15/2024267,200 shares $181,241.76 -3.3%N/A0.8 $0.68 7/31/2024276,400 shares $217,084.56 +130.9%N/A0.8 $0.79 7/15/2024119,700 shares $90,972.00 -63.1%N/A0.3 $0.76 6/30/2024324,300 shares $184,818.57 +52.9%N/A0.9 $0.57 6/15/2024212,100 shares $141,661.59 -40.5%N/A0.5 $0.67 5/31/2024356,200 shares $265,582.72 +62.6%N/A0.8 $0.75 5/15/2024219,100 shares $135,173.75 -46.6%N/A0.5 $0.62 4/30/2024410,600 shares $274,855.64 -47.6%N/A1 $0.67 4/15/2024783,600 shares $504,560.04 +32.5%N/A1.8 $0.64 3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12 3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15 2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33 2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11 1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19 1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41 12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57 12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59 11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45 11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69 10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50 10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60 9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82 9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95July 2025 Rule Change to Impact Retirement Investors (Ad)There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.Yes, Send Me My FREE Retirement Guide 8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75 8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49 7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54 7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67 6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60 6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77 5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58 5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38 4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07 4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10 3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89 3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61 2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60 2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62 1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63 1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69 12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59 12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64 11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70 11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68 10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85 10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84 9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93 9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59 8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52 8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91 7/31/2022384,000 shares $506,880.00 -6.6%N/A2.8 $1.32 7/15/2022411,200 shares $551,008.00 +14.8%N/A2.7 $1.34 6/30/2022358,100 shares $458,368.00 +3.7%N/A2.2 $1.28 6/15/2022345,400 shares $466,290.00 -18.1%N/A2 $1.35 5/31/2022421,800 shares $658,008.00 -11.7%N/A2.3 $1.56 5/15/2022477,400 shares $572,880.00 +30.8%N/A2.3 $1.20 4/30/2022365,000 shares $445,300.00 -9.5%N/A1.8 $1.22 4/15/2022403,300 shares $621,082.00 -20.8%N/A2 $1.54 3/31/2022509,200 shares $870,732.00 -11.3%N/A2.1 $1.71 3/15/2022574,100 shares $878,373.00 +14.7%N/A2 $1.53 2/28/2022500,700 shares $761,064.00 -6.1%N/A1.2 $1.52 2/15/2022533,400 shares $938,784.00 +25.9%N/A1.2 $1.76 1/31/2022423,800 shares $771,316.00 +6.5%N/A0.9 $1.82 1/15/2022398,100 shares $800,181.00 +21.4%N/A0.9 $2.01 12/31/2021328,000 shares $669,120.00 +19.5%N/A0.6 $2.04 12/15/2021274,600 shares $648,056.00 +135.3%N/A0.6 $2.36 11/30/2021116,700 shares $306,921.00 -36.8%N/A0.3 $2.63 11/15/2021184,500 shares $527,670.00 +18.0%N/A0.5 $2.86 10/29/2021156,400 shares $444,176.00 -54.1%N/A0.4 $2.84 10/15/2021340,700 shares $1.04 million +65.3%N/A0.8 $3.06 9/30/2021206,100 shares $566,775.00 +8.5%N/A0.4 $2.75 9/15/2021190,000 shares $513,000.00 -34.7%N/A0.2 $2.70 8/31/2021291,000 shares $835,170.00 +5.0%N/A0.3 $2.87 8/13/2021277,100 shares $836,842.00 +3.2%N/A0.3 $3.02Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 7/30/2021268,500 shares $867,255.00 +228.2%N/A0.2 $3.23 7/15/202181,800 shares $273,212.00 -27.2%N/A0 $3.34 6/30/2021112,300 shares $315,563.00 -64.8%N/A0 $2.81 6/15/2021319,100 shares $890,289.00 -50.7%N/A0.1 $2.79 5/28/2021647,600 shares $1.85 million +15.8%N/A0.1 $2.86 5/14/2021559,500 shares $1.59 million +27.6%N/A0.1 $2.85 4/30/2021438,500 shares $1.34 million +9.3%N/A0.1 $3.05 4/15/2021401,200 shares $1.10 million -3.0%N/A0.3 $2.73 3/31/2021413,400 shares $1.17 million -7.0%N/A0.2 $2.82 3/15/2021444,600 shares $1.35 million -34.2%N/A0.2 $3.03 2/26/2021675,400 shares $2.18 million -62.5%N/A0.3 $3.23 2/12/20211,800,000 shares $6.68 million +0.6%N/A0.7 $3.71 1/29/20211,790,000 shares $5.24 million -27.8%N/A0.7 $2.93 1/15/20212,480,000 shares $6.94 million +0.8%N/A0.4 $2.80 12/31/20202,460,000 shares $6.27 million -2.4%N/A0.4 $2.55 12/15/20202,520,000 shares $8.54 million +11.5%N/A0.5 $3.39 11/30/20202,260,000 shares $5.24 million -8.9%N/A0.5 $2.32 11/15/20202,480,000 shares $5.83 million +79.7%N/A0.5 $2.35 10/30/20201,380,000 shares $2.04 million -8.0%N/A0.3 $1.48 10/15/20201,500,000 shares $2.41 million No ChangeN/A6.1 $1.61 9/30/20201,500,000 shares $2.46 million -1.3%N/A4.5 $1.64 9/15/20201,520,000 shares $2.64 million -1.3%N/A4.2 $1.74 8/31/20201,540,000 shares $2.80 million -7.2%N/A3.5 $1.82 8/14/20201,660,000 shares $3.40 million +12.2%N/A2.3 $2.05 7/31/20201,480,000 shares $3.36 million +114.6%N/A2.1 $2.27 7/15/2020689,800 shares $1.22 million +60.2%N/A1.1 $1.77 6/30/2020430,600 shares $736,326.00 +7.3%N/A0.8 $1.71 6/15/2020401,200 shares $649,944.00 +432.8%N/A0.8 $1.62 5/29/202075,300 shares $146,082.00 +2.5%N/A0.2 $1.94 BLRX Short Interest - Frequently Asked Questions What is BioLineRx's current short interest? Short interest is the volume of BioLineRx shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 198,800 shares of BLRX short. 5.37% of BioLineRx's shares are currently sold short. Learn More on BioLineRx's current short interest. What is a good short interest ratio for BioLineRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLRX shares currently have a short interest ratio of 5.0. Learn More on BioLineRx's short interest ratio. What is a good short interest percentage for BioLineRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.37% of BioLineRx's floating shares are currently sold short. Is BioLineRx's short interest increasing or decreasing? BioLineRx saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 198,800 shares, a decrease of 8.5% from the previous total of 217,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioLineRx's float size? BioLineRx currently has issued a total of 3,329,000 shares. Some of BioLineRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioLineRx currently has a public float of 3,700,000 shares. How does BioLineRx's short interest compare to its competitors? 5.37% of BioLineRx's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioLineRx: Alterity Therapeutics Limited (0.35%), RenovoRx, Inc. (0.72%), Atara Biotherapeutics, Inc. (13.67%), Prelude Therapeutics Incorporated (3.60%), Xilio Therapeutics, Inc. (2.22%), SCYNEXIS, Inc. (1.64%), Acrivon Therapeutics, Inc. (6.39%), Barinthus Biotherapeutics plc (0.14%), Akari Therapeutics, Plc (0.42%), Estrella Immunopharma, Inc. (0.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short BioLineRx stock? Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLineRx? A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further. How often is BioLineRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies ATHE Short Interest RNXT Short Interest ATRA Short Interest PRLD Short Interest XLO Short Interest SCYX Short Interest ACRV Short Interest BRNS Short Interest AKTX Short Interest ESLA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLRX Stock Free BLRX Stock Alerts